Injection Site Reactions in the Federal Adverse Event Reporting System (FAERS) Post-Marketing Database Vary Among Biologics Approved to Treat Moderate-To-Severe Psoriasis

INTRODUCTION: Biologics used to treat moderate-to-severe plaque psoriasis may cause injection site reactions (ISRs) characterized by erythema, edema, itch, and sometimes pain. The Federal Adverse Event Reporting System (FAERS) is a repository of spontaneous post-marketing reports of adverse events (...

Descripción completa

Detalles Bibliográficos
Autores principales: Grace, Elsie, Goldblum, Orin, Renda, Lisa, Agada, Noah, See, Kyoungah, Leonardi, Craig, Menter, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994575/
https://www.ncbi.nlm.nih.gov/pubmed/31734937
http://dx.doi.org/10.1007/s13555-019-00341-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994575/
https://www.ncbi.nlm.nih.gov/pubmed/31734937
http://dx.doi.org/10.1007/s13555-019-00341-2

Ejemplares similares